Skin CancerCore · 8 min read

Melanoma: Pattern Analysis & Diagnosis

Multicomponent asymmetric architecture, atypical network, blue-white veil, regression, and atypical vessels define the dermoscopic vocabulary of cutaneous melanoma.

By Dr. Yehonatan KaplanPublished Updated

In brief

Melanoma displays a characteristic disorganization that dermoscopy uncovers before the naked eye recognizes it. The diagnostic strategy combines two layers: a global pattern (typically multicomponent and asymmetric) and a roster of local features that map to specific histopathologic events at the dermoepidermal junction or within the dermis. Three meta-analyses and two randomized trials confirm that dermoscopy raises sensitivity for melanoma from approximately 74% (naked eye) to 90% without loss of specificity.

Clinical content

01Superficial spreading melanoma (SSM) is the archetype that anchors most dermoscopic teaching. Junctional features (atypical network, irregular dots, irregular globules, irregular streaks/pseudopods, irregular blotches) reflect heterogeneous melanocytic nests at the dermoepidermal junction. Mixed junctional-dermal features (regression structures, negative network, white shiny streaks) reflect the regression process and dermal fibrosis. Dermal features (blue-white veil, atypical vessels) signal invasion. Most early SSMs display a multicomponent global pattern, but a subset of in situ tumors still show a reticular or globular pattern with subtle asymmetry.

02Nodular melanoma lacks the junctional vocabulary because the tumor invades the dermis from the outset. Three criteria carry the diagnosis: blue-black coloration (simultaneous blue and black within a single lesion not explained by comedo-like openings or vascular lacunas), atypical vascular pattern (linear-irregular vessels, polymorphic vessels, or more than two vessel types), and milky-red structureless pink. Any nodular lesion that cannot be confidently classified should be excised; nodular melanoma kills disproportionately because diagnosis is delayed.

03Lentigo maligna and acral lentiginous melanoma require site-specific frameworks because the dermoepidermal junction is anatomically flattened (face) or elaborated into ridges and furrows (palms and soles). Network is rarely seen on the face; instead, lentigo maligna features develop around the follicular openings (asymmetric pigmented follicles, gray dots, gray circles, rhomboidal structures, target-like patterns). On acral skin, the parallel ridge pattern (pigment on ridges) discriminates from the parallel furrow pattern (pigment in furrows) of nevi.

04Atypical pigment network is heterogeneous in line thickness, hole size, and color across the lesion. It corresponds to irregular and broadened rete ridges with uneven nest distribution. The thin and uniform network of benign nevi contrasts with the broadened and abruptly ending network of melanoma. Atypical network was the most frequent SSM feature historically, but recent in-situ data suggest that irregular hyperpigmented areas and prominent skin markings may be more sensitive in early lesions.

05Blue-white veil is an irregularly shaped blotch of blue color with overlying white ground-glass haze. Histopathologically it represents acanthotic epidermis with focal hypergranulosis above sheets of heavily pigmented dermal melanocytes. With non-polarized dermoscopy the veil appears as a confluent blue-white area; with polarized light the same anatomy presents as blue structureless color plus white shiny strands. Blue-white veil signals dermal invasion and correlates with tumor thickness over 0.8 mm.

06Regression structures take two forms. Blue-gray peppering (free melanin and melanophages in the upper dermis) marks active regression and can occur in melanoma, regressing nevi, and lichen planus-like keratosis. Scar-like white depigmentation (dermal fibrosis) marks completed regression and is unusual in benign lesions outside dermatofibromas. Extensive regression occupying more than half a lesion is suggestive but not pathognomonic; the regression-with-melanoma-features rule (regression plus any other melanoma criterion) reliably triggers excision.

07Atypical vessels in melanoma are polymorphic. The most informative are linear-irregular vessels (vessels with multiple kinks and bends), corkscrew vessels (looped vessels twisted around an axis), and the combination of dotted plus short linear vessels in flat amelanotic lesions. The presence of more than one vessel morphology in a solitary lesion is itself a melanoma cue. Milky-red areas (structureless pink) often coexist with atypical vessels and signal angiogenesis in vertical-growth-phase tumors.

08Amelanotic and hypomelanotic melanoma lacks pigment-based criteria, forcing reliance on vessel morphology. Polymorphic vessels (multiple morphologies in one lesion), milky-red areas, white shiny structures, and residual pink-red coloration on a lesion arising in light skin warrant excision. Roughly 10% of melanomas are amelanotic or hypomelanotic, and these account for a disproportionate share of missed diagnoses.

09Sequential dermoscopy and the evolution criterion (E in ABCDE) capture melanomas that lack baseline diagnostic features. Argenziano's monitoring data showed that 7 of 12 melanomas detected during follow-up appeared after 8 to 54 months, supporting both short-term (3-month) monitoring for highly suspicious lesions and long-term annual monitoring for slow-growing tumors. Any change in size, color, or structure on a flat melanocytic lesion in an adult is a hard indication for excision.

Key dermoscopic features

Atypical network
Heterogeneous junctional melanocyte nests; classic SSM featureNetwork with irregular hole size and line thickness, color heterogeneity, and abrupt ending at the periphery
Irregular globules and dots
Asymmetric junctional and intraepidermal melanocytic aggregatesBlack-brown globules of varying size and irregular distribution; black dots scattered above the network
Irregular streaks and pseudopods
Confluent peripheral nests in radial-growth phase melanomaLinear or bulbous projections at the lesion edge, asymmetrically distributed (contrast with symmetric starburst of Reed nevus)
Blue-white veil
Dermal invasion; tumor thickness usually >0.8 mmConfluent blue blotch with overlying whitish ground-glass haze, asymmetrically distributed
Regression structures
Active or completed immune-mediated regressionBlue-gray peppering (melanophages) and/or scar-like white depigmentation (fibrosis), often eccentric
Negative network
Inverse pigment distribution; seen in melanoma and Spitz neviHypopigmented serpiginous lines surrounding elongated and curvilinear pigmented globules
White shiny streaks (chrysalis)
Dermal fibrosis or acanthosis; visible only with polarized lightShort white lines oriented orthogonally to one another; thin streaks in lesions under 0.8 mm, thicker strands in deeper tumors
Polymorphic atypical vessels
Angiogenesis in invasive or amelanotic melanomaLinear-irregular, corkscrew, dotted, and short-linear vessels coexisting in a single lesion
Milky-red areas
Vertical-growth phase or amelanotic melanomaStructureless pink-red zones, often with embedded atypical vessels, lacking organized structure
Irregular blotch (eccentric)
Heterogeneous pigment concentrated asymmetricallyDark brown to black structureless area with irregular shape, located off-center
Irregular hyperpigmented areas
Recently described, strongest predictor of melanoma in situSmall, irregular dark brown to black structures probably reflecting upward melanocyte migration
Multicomponent global pattern
Three or more dermoscopic structures coexisting asymmetricallyCombination of network, globules, structureless, and blue-white veil without symmetric organization

High yield clinical points15 pearls in 5 groups

Recognition & pattern analysis

5 points
1
Polymorphic vessels in a solitary lesion. More than one vessel morphology in a single lesion is itself a malignancy cue, especially when paired with a flat or amelanotic surface. Dotted plus short-linear is the most common combination in early SSM.
2
Black dots above network = upward migration. Scattered black dots that sit above network lines and outside network holes correspond to pagetoid melanocyte migration into the upper epidermis. They are highly specific for melanoma.
3
Streaks: symmetric Reed vs asymmetric melanoma. A starburst with streaks in a child or young adult on face/limb/buttock is a Reed nevus. The same morphology adult-onset, asymmetric, or on uncommon sites is a melanoma differential.
4
Negative network in nevus-associated melanoma. Negative network (hypopigmented lines surrounding pigmented globules) is reported more frequently in nevus-associated than in de-novo melanoma and is also seen in Spitz nevi. Asymmetric distribution favors melanoma.
5
White shiny streaks are polarization-only. Crystalline structures (white shiny streaks, chrysalis) are visible only under polarized dermoscopy. Compare with non-polarized images: an area that looks unstructured non-polarized but reveals shiny streaks under polarization is highly suspicious.

Diagnostic criteria & thresholds

4 points
1
Architectural disorder beats individual criteria. In Carrera's web-based reliability study, asymmetry of pattern and color outperformed every single local criterion in both discriminatory power and inter-rater agreement. Train the eye to recognize disorder before counting features.
74%
Dermoscopy adds 16% sensitivity without specificity loss. Vestergaard's 2008 meta-analysis showed naked-eye sensitivity 74% versus dermoscopy 90%, with comparable specificity (around 80%). The improvement is real and clinically translatable.
3
In situ has its own dictionary. Lallas's in-situ analysis showed that irregular hyperpigmented areas and prominent skin markings outperformed traditional criteria. The classical SSM features were derived from invasive tumors and undercall the earliest lesions.
4
Blue-black rule for nodular melanoma. Simultaneous blue and black within a nodular lesion (not from comedo-like openings or vascular lacunas) is a simple high-specificity rule that flags pigmented nodular melanoma without requiring full pattern analysis.

Pitfalls & mimics

1 point
10%
Amelanotic melanoma hides in vessels. Pink lesion plus polymorphic vessels plus white shiny structures equals amelanotic melanoma until proved otherwise. Roughly 10% of melanomas lack pigment, and this group drives missed diagnoses.

When to biopsy

3 points
1
Multicomponent + asymmetry = excise. A multicomponent global pattern with any asymmetry of structure or color is the single strongest screening rule. Most invasive SSMs and many in situ tumors satisfy this rule.
2
Blue-white veil signals depth. When present, blue-white veil correlates with Breslow thickness over 0.8 mm. It rarely appears in early in-situ lesions, so its absence does not exclude melanoma but its presence mandates wide excision and staging.
3
Regression plus anything = excise. Extensive regression alone overlaps with regressing nevi and lichen planus-like keratosis. Regression plus any single melanoma criterion (atypical network, irregular pigmentation, polymorphic vessels) reliably identifies melanoma.

Follow-up & monitoring

2 points
3%
Sequential imaging catches featureless melanoma. About 3% of patients with multiple atypical nevi develop a melanoma during digital follow-up, often discovered through change rather than baseline criteria. Schedule the first re-check at 3 months for compliance.
2
Slow-growing melanomas exist. A subset of melanomas evolve over years rather than months, picked up only by long-term monitoring. Annual follow-up of high-risk patients catches these despite normal short-term comparisons.

Lectures covering this topic19 lectures

AAD 2026F036 · #02
Melanoma and its Mimics
Kelly C. Nelson, MD, FAAD
AAD 2026F042 · #01
Invasive vs In Situ Melanomas
Konstantinos Liopyris, MD, PhD
AAD 2026S001 · #01
Dermatoscopy of Melanoma
Dawn Hirokawa, MD, MPH
AAD 2026U041 · #01
Dermoscopy Quiz
David L. Swanson, MD
AAD 2026U101 · #01
Challenges in Diagnosis and Management of Dysplastic Nevi
Speaker as listed in AAD program
Excellence (main)DE-MAIN · #02
Nevi Basics and Melanoma Basics
G. Argenziano and A. Lallas
Excellence Intl 2025DE-INTL · #03
Age Matters: Clinical Clues for Melanoma Screening
Giuseppe Argenziano
Excellence Intl 2025DE-INTL · #08
WHO Classification of Melanocytic Tumors, Clinician View
Giuseppe Argenziano
Excellence Intl 2025DE-INTL · #09
Decoding the Mind: Pigmented Lesions
Aimilios Lallas
Excellence Intl 2025DE-INTL · #11
Diving Into the Blue
Aimilios Lallas
Excellence PracticalDE-PRACT · #01
Melanoma Basic Cases
Giuseppe Argenziano and Aimilios Lallas
Excellence PracticalDE-PRACT · #02
Facial Cases
Giuseppe Argenziano and Aimilios Lallas
Academy 2025ACAD25 · #04
Decoding Melanocytic Lesions (Nevi and Melanoma)
Aimilios Lallas
Academy 2025ACAD25 · #07
What's New About Melanoma Diagnosis
Giuseppe Argenziano
Academy 2025ACAD25 · #15
Deep Into Blue-Gray Color
Aimilios Lallas
Academy 2025ACAD25 · #16
Diving Into White Color
Aimilios Lallas
ADM 2025ANNUAL13 · #02
Approach to Evaluating Facial Lesions
Harold Rabinovitz, MD
ADM 2025ANNUAL13 · #20
Melanoma-Specific Structures
Natalia Jaimes, MD
ADM 2025ANNUAL13 · #27
The Universe of Nevi
Ashfaq A. Marghoob, MD

Notable updates & conceptual milestones7 updates

Three meta-analyses confirming dermoscopy benefit

2008

Bafounta 2001, Kittler 2002, and Vestergaard 2008 collectively established that dermoscopy raises melanoma sensitivity by 14-19% over naked eye in clinical settings without specificity loss, ending two decades of debate.

Pattern analysis (Pehamberger 1987)

1987

The original method that defined dermoscopic criteria and remains the reference standard against which all later algorithms are validated.

Seven-point checklist (Argenziano 1998)

1998

Three major (atypical network, blue-white veil, atypical vascular pattern) and four minor criteria (irregular streaks, irregular pigmentation, irregular dots/globules, regression structures) with a simple scoring system. Performs comparably to ABCD with greater simplicity.

Irregular hyperpigmented areas for melanoma in situ

2018

Lallas 2018 demonstrated that classical criteria undercall in-situ lesions and that irregular hyperpigmented areas plus prominent skin markings are the strongest in-situ predictors, prompting an update to the melanoma-criterion list.

Sequential dermoscopic imaging protocols

2008

Short-term (3-month) versus long-term (annual) monitoring strategies, with documented melanoma detection rates around 3% in patients with multiple atypical nevi and improved patient compliance for short-term protocols.

AI dermoscopy meta-analysis (38 studies)

2025

A 2025 meta-analysis pooling AI dermoscopy across 38 studies reported sensitivity 0.86 and specificity 0.94 for melanoma detection, comparable to dermatologists. Dataset selection bias inflates real-world expectations and AI is best positioned as a second reader.

3D total-body photography RCT

2025

A 2025 randomized trial showed 3D total-body photography with teledermatology review in high-risk patients did not reduce melanoma incidence and increased per-person biopsy rates compared with usual care, indicating imaging without AI triage can drive overcalling.

Bottom line

Multicomponent asymmetric architecture, atypical network, blue-white veil, regression, and atypical vessels define the dermoscopic vocabulary of cutaneous melanoma.

15 clinical points · 7 recent updates · 13 references

Source content

AAD 2026 · U004 · #03

Dermoscopy to the Rescue: Melanoma

Kelly C. Nelson, MD, FAAD · MD Anderson Cancer Center, Houston, Texas

AAD 2026 · F036 · #02

Melanoma and its Mimics

Kelly C. Nelson, MD, FAAD · MD Anderson Cancer Center, Houston, Texas

AAD 2026 · F042 · #01

Invasive vs In Situ Melanomas

Konstantinos Liopyris, MD, PhD · AAD 2026 Dermoscopy Symposium

AAD 2026 · S001 · #01

Dermatoscopy of Melanoma

Dawn Hirokawa, MD, MPH · Mass General Brigham

References

Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.

  1. [1]
    Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions, a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001;2:443-449.
    PubMed: 11905739DOI: 10.1016/S1470-2045(00)00422-8· Synthesis of pattern analysis, ABCD, Menzies, and 7-point methods plus follow-up principles.
  2. [2]
    Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008;159:669-676.
    PubMed: 18616769DOI: 10.1111/j.1365-2133.2008.08713.x· Definitive meta-analysis quantifying dermoscopy's incremental sensitivity.
  3. [3]
    Lallas A, Longo C, Manfredini M, et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol 2018;154:414-419.
    PubMed: 29466542DOI: 10.1001/jamadermatol.2017.6447· Demonstrated that irregular hyperpigmented areas and prominent skin markings are the strongest in-situ predictors.
  4. [4]
    Carrera C, Marchetti MA, Dusza SW, et al. Validity and reliability of dermoscopic criteria used to differentiate nevi from melanoma: a Web-based International Dermoscopy Society study. JAMA Dermatol 2016;152:798-806.
    PubMed: 27074267DOI: 10.1001/jamadermatol.2016.0624· Architectural disorder and asymmetry outperform individual local features in reliability and discriminatory power.
  5. [5]
    Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48:679-693.
    PubMed: 12734496DOI: 10.1067/mjd.2003.281· Standardized criteria and the two-step diagnostic algorithm used worldwide.
  6. [6]
    Kittler H, Marghoob AA, Argenziano G, et al. Standardization of terminology in dermoscopy/dermatoscopy: results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol 2016;74:1093-1106.
    PubMed: 26896294DOI: 10.1016/j.jaad.2015.12.038· Authoritative source for dermoscopic terminology used in the criteria descriptions.
  7. [7]
    Argenziano G, Mordente I, Ferrara G, Sgambato A, Annese P, Zalaudek I. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008;159:331-336.
    PubMed: 18510663DOI: 10.1111/j.1365-2133.2008.08649.x· Empirical basis for short-term versus long-term monitoring protocols.
  8. [8]
    Nadour N, Duguet T, Zahedi S, et al. Diagnostic accuracy of artificial intelligence compared to family physicians and dermatologists for skin conditions: a systematic review and meta-analysis. BMC Prim Care. 2025;26(1):384.
    PubMed: 41315984DOI: 10.1186/s12875-025-03073-9· Meta-analysis of 38 studies; AI dermoscopy sensitivity 0.86 and specificity 0.94 for melanoma detection.
  9. [9]
    Soyer HP, Jayasinghe D, Rodriguez-Acevedo AJ, et al. 3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial. JAMA Dermatol. 2025;161(5):472-481.
    PubMed: 40136310DOI: 10.1001/jamadermatol.2025.0211· RCT of 3D-TBP plus teledermatology in high-risk patients did not reduce melanoma incidence and increased biopsy rate.
  10. [10]
    Lindsay D, Soyer HP, Janda M, et al. Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma. JAMA Dermatol. 2025;161(5):482-489.
    PubMed: 40136266DOI: 10.1001/jamadermatol.2025.0219· Cost-effectiveness companion: extra US$945 per person over two years with no QALY gain, supporting selective use.
  11. [11]
    Varga NN, Gulyas L, Meznerics FA, et al. Diagnostic Accuracy of Novel Optical Imaging Techniques for Melanoma Detection: A Systematic Review and Meta-Analysis. Int J Dermatol. 2025;64(10):1813-1824.
    PubMed: 40339039DOI: 10.1111/ijd.17828· Meta-analysis of 138 studies positioning RCM and AI-augmented dermoscopy as second-step evaluation; AI plus dermoscopy sensitivity 0.93, specificity 0.77.
  12. [12]
    Musolff N, Tchack M, Chaudhry ZS, Sanabria B, Rao B. Updates in Dermoscopy for Pigmented Lesions. Dermatol Clin. 2025;43(3):419-432.
    PubMed: 40581422DOI: 10.1016/j.det.2025.03.009· 2025 review consolidating modern pigmented-lesion algorithms (ABCDE, 7-point, ASAP) with newer pattern criteria.
  13. [13]
    Zboraș I, Ungureanu L, Șenilă SC, et al. Comparative Dermoscopic Analysis of Melanoma In Situ Versus Thin Invasive Melanoma Considering BRAF Mutational Status. J Clin Med. 2025;14(18):6554.
    PubMed: 41010758DOI: 10.3390/jcm14186554· Five features (irregular dots and globules, blue-white veil, milky red areas, dotted vessels, linear irregular vessels) distinguish thin invasive from in situ; BRAF status not predictable from dermoscopy.